10 facts about levofloxacin Review article

Main Article Content

Anna Katarzyna Czech
Piotr L. Chłosta

Abstract

Levofloxacin is a bactericidal drug belonging to the fluoroquinolone group. It has a broad spectrum of antimicrobial activity, including Gram-positive, Gram-negative bacteria, selected anaerobes and atypical microorganisms. Levofloxacin can be administered intravenously and orally. Once-a-day dosing and the ability to be taken with or without food make for greater convenience. Levofloxacin achieves high concentration in urine and penetrates well into the prostate gland. It is used in the treatment of uncomplicated pyelonephritis in women, urinary tract infections in men, complicated urinary tract infections, acute and chronic prostatitis, epididymitis, and in the treatment of respiratory, skin and soft tissue infections.

Article Details

How to Cite
Czech, A. K., & Chłosta , P. L. (2022). 10 facts about levofloxacin. Medycyna Faktow (J EBM), 15(3(56), 324-326. https://doi.org/10.24292/01.MF.0322.9
Section
Articles

References

1. Indeks leków Medycyny Praktycznej: lewofloksacyna (levofloxacin) (access: 15.06.2022).
2. Dutkiewicz S, Czyrniański R. Lewofloksacyna – optymalne połączenie skuteczności i bezpieczeństwa. Przegląd piśmiennictwa. Przewodnik Lekarza. 2012; suppl 1: 3-10.
3. Dutkiewicz S. Lewofloksacyna – fluorochinolon IV generacji. Rola i znaczenie w zakażeniach układu moczowo-płciowego. Przegląd Urologiczny. 20212; 2(72).
4. Falagas ME, Karagiannis AKA, Nakouti T et al. Compliance with Once-Daily versus Twice or Thrice-Daily Administration of Antibiotic Regimens: A Meta-Analysis of Randomized Controlled Trials. PLoS One. 2015; 10(1): e0116207.
5. Bonkat G, Bartoletti R, Bruyere F et al. EAU Guidelines on Urological Infections 2022 (access: 15.06.2022).
6. Dzierżanowska-Fangrat K. Przewodnik antybiotykoterapii 2022. Alfa Medica Press, Bielsko-Biała 2022.